Summit X’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ARMP
Summit X's ARMP Position: Q2 2019 in Review
Summit X sold out of Armata Pharmaceuticals (ARMP) in Q2 2019, closing a stake of 4,057 shares — an estimated $18K sold.
Summit X first reported a position in ARMP in Q3 2017 and held it in 7 quarters. The position peaked at $33K in Q2 2018. 12 funds tracked by Wall St. Rank hold ARMP as of Q2 2019.
- Summit X reported no remaining Armata Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
- Summit X sold 4,057 Armata Pharmaceuticals shares in Q2 2019, an estimated $18K.
- Summit X first reported a position in Armata Pharmaceuticals in Q3 2017 and held it in 7 quarters.
- Summit X's Armata Pharmaceuticals position peaked at $33K in Q2 2018.
- 12 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2019.
Based on Summit X's 13F filing for Q2 2019, filed 13 Aug 2019.